Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.
Símbolo de cotizaciónCERT
Nombre de la empresaCertara Inc
Fecha de salida a bolsaDec 11, 2020
Director ejecutivoFeehery (William F)
Número de empleados1487
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 11
Dirección4 Radnor Corporate Center, Suite 350
CiudadRADNOR
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal19087
Teléfono14152378272
Sitio Webhttps://www.certara.com/
Símbolo de cotizaciónCERT
Fecha de salida a bolsaDec 11, 2020
Director ejecutivoFeehery (William F)
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos